Evidence map›Paper›PMID 36009448›Full record

ArticleBiomedicines2022

Elevated Vascular Sympathetic Neurotransmission and Remodelling Is a Common Feature in a Rat Model of Foetal Programming of Hypertension and SHR.

Maria Sofia Vieira-Rocha, Joana Beatriz Sousa, Pilar Rodríguez-Rodríguez, Silvia Madaglena Arribas, Carmen Diniz

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Maria Sofia Vieira-RochaLaboratory of Pharmacology, Department of Drug Science, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Joana Beatriz SousaLaboratory of Pharmacology, Department of Drug Science, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Pilar Rodríguez-RodríguezDepartment of Physiology, Faculty of Medicine, Universidad Autonoma de Madrid, 28029 Madrid, Spain.
Silvia Madaglena ArribasDepartment of Physiology, Faculty of Medicine, Universidad Autonoma de Madrid, 28029 Madrid, Spain.
Carmen DinizLaboratory of Pharmacology, Department of Drug Science, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0003-4668-9360
Universidade do Porto · PTUniversidad Autónoma de Madrid · ES

Funding

Fundação para a Ciência e Tecnologia UIDB/QUI/50006/2020Spanish Ministry of Science and Innovation TI 2018-097504-B-I00
6 · The paper itself

Abstract

Hypertension is of unknown aetiology, with sympathetic nervous system hyperactivation being one of the possible contributors. Hypertension may have a developmental origin, owing to the exposure to adverse factors during the intrauterine period. Our hypothesis is that sympathetic hyperinnervation may be implicated in hypertension of developmental origins, being this is a common feature with essential hypertension. Two-animal models were used: spontaneously hypertensive rats (SHR-model of essential hypertension) and offspring from dams exposed to undernutrition (MUN-model of developmental hypertension), with their respective controls. In adult males, we assessed systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), sympathetic nerve function (

Indexed as

fibrosisfoetal programming of hypertensionfoetal undernutritionsympathetic innervationsympathetic neurotransmissionvascular remodelling

Identifiers

PMID36009448
PMCPMC9405620
OpenAlexW4290467256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.